What is he best known for?
The fields of study he is best known for:
- Gene
- Cancer
- Immune system
Xueguang Zhang mainly investigates Immune system, Pathology, Immunology, Cancer research and Internal medicine.
His study in Immune system is interdisciplinary in nature, drawing from both Cancer cell, Interleukin 12 and Cell biology.
The various areas that Xueguang Zhang examines in his Immunology study include Clinical uses of mesenchymal stem cells, Amniotic epithelial cells, Adult stem cell and Polysaccharide.
His research integrates issues of microRNA, Prostate-specific antigen, Prostate cancer, Hyperplasia and Multiple myeloma in his study of Cancer research.
His studies in Internal medicine integrate themes in fields like Endocrinology, Oncology and Gene expression profiling.
His Immunohistochemistry research includes elements of PD-L1, Pathological and Adenoma.
His most cited work include:
- Generation of gene-modified mice via Cas9/RNA-mediated gene targeting. (489 citations)
- High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation (408 citations)
- Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance (382 citations)
What are the main themes of his work throughout his whole career to date?
Molecular biology, Immunology, Cancer research, Immune system and T cell are his primary areas of study.
His research in Molecular biology intersects with topics in Cell culture, Transfection, Monoclonal antibody and Antigen.
His Immunology research incorporates themes from Internal medicine and Clinical significance.
Xueguang Zhang focuses mostly in the field of Cancer research, narrowing it down to topics relating to Cancer and, in certain cases, Oncology and Pathology.
His specific area of interest is Immune system, where Xueguang Zhang studies CD8.
His T cell study combines topics from a wide range of disciplines, such as Tumor microenvironment and Cell biology.
He most often published in these fields:
- Molecular biology (30.18%)
- Immunology (27.64%)
- Cancer research (22.55%)
What were the highlights of his more recent work (between 2015-2021)?
- Cancer research (22.55%)
- Immunology (27.64%)
- Immune system (19.64%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Cancer research, Immunology, Immune system, Molecular biology and Cell.
His biological study spans a wide range of topics, including Cancer cell, Cancer, Colorectal cancer, Gene knockdown and PI3K/AKT/mTOR pathway.
His work on T cell, CD28 and IL-2 receptor as part of his general Immunology study is frequently connected to Hepatitis B virus, thereby bridging the divide between different branches of science.
His Immune system research is multidisciplinary, incorporating perspectives in Immunohistochemistry and Neuromyelitis optica.
His studies deal with areas such as Cell culture, Angiogenesis, Antibody, Monoclonal antibody and B-cell activating factor as well as Molecular biology.
His Cell research includes themes of Apoptosis, Stem cell and Cell growth.
Between 2015 and 2021, his most popular works were:
- PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer. (42 citations)
- TGF-β1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis. (42 citations)
- B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2. (39 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Cancer
- Immune system
Xueguang Zhang mostly deals with Cancer research, Immunology, T cell, Immune system and Cancer cell.
His Cancer research research integrates issues from Tumor microenvironment, PD-L1, CD8 and Colorectal cancer.
Xueguang Zhang has researched Immunology in several fields, including Hepatocellular carcinoma, Internal medicine and Clinical significance.
His Internal medicine research is multidisciplinary, relying on both CD28, Adoptive cell transfer and Interleukin 21.
His work deals with themes such as Transforming growth factor, Cellular differentiation, PI3K/AKT/mTOR pathway and Janus kinase, which intersect with T cell.
His biological study spans a wide range of topics, including Immunohistochemistry, Cell, Infiltration and Uicc stage.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
